The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Global epidemiology and burden of HCV infection and HCV-related disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Self-citationNatural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
Global epidemiology and genotype distribution of the hepatitis C virus infection
Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.027 · Cited by 1,903
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Afdhal, N., Zeuzem, S., Kwo, P., Chojkier, M., Gitlin, N., Puoti, M., Romero-Gomez, M., Zarski, J.-P., Agarwal, K., Buggisch, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402454 · Cited by 1,705
Global distribution and prevalence of hepatitis C virus genotypes
Messina, J. P., Humphreys, I., Flaxman, A., Brown, A., Cooke, G. S., Pybus, O. G., & Barnes, E. (2015) · Hepatology · doi:10.1002/hep.27259 · Cited by 1,589
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H., Dufour, J.-F., Lammert, F., Duarte-Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,510
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz, E., Gordon, S. C., Schiff, E., Nahass, R., Ghalib, R., Gitlin, N., Herring, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316366 · Cited by 1,307
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Reig, M., Mariño, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.008 · Cited by 1,018
Risk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
Self-citationClinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
Feld, J. J., Kowdley, K. V., Coakley, E., Sigal, S., Nelson, D. R., Crawford, D., Weiland, O., Aguilar, H., Xiong, J., Pilot-Matias, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315722 · Cited by 903
Conti, F., Buonfiglioli, F., Scuteri, A., Crespi, C., Bolondi, L., Caraceni, P., Foschi, F. G., Lenzi, M., Mazzella, G., Verucchi, G., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.015 · Cited by 897
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Johnson, R. J., Gretch, D. R., Yamabe, H., Hart, J., Bacchi, C. E., Hartwell, P., Couser, W. G., Corey, L., Wener, M. H., Alpers, C. E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280703 · Cited by 879
Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
Self-citationABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Poordad, F., Hezode, C., Trinh, R., Kowdley, K. V., Zeuzem, S., Agarwal, K., Shiffman, M. L., Wedemeyer, H., Berg, T., Yoshida, E. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402869 · Cited by 874
Thein, H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · Hepatology · doi:10.1002/hep.22375 · Cited by 829
Morgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Self-citationRates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
Ly, K. N., Xing, J., Klevens, R. M., Jiles, R. B., Ward, J. W., & Holmberg, S. D. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-4-201202210-00004 · Cited by 711
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El-Serag, H. B. (2005) · Gut · doi:10.1136/gut.2004.052167 · Cited by 704
Self-citationABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Ferenci, P., Bernstein, D., Lalezari, J., Cohen, D., Luo, Y., Cooper, C., Tam, E., Marinho, R. T., Tsai, N., Nyberg, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402338 · Cited by 693
Roth, D., Nelson, D. R., Bruchfeld, A., Liapakis, A., Silva, M., Monsour, H., Martin, P., Pol, S., Londoño, M.-C., Hassanein, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00349-9 · Cited by 671
Mittal, S., El-Serag, H. B., Sada, Y. H., Kanwal, F., Duan, Z., Temple, S., May, S. B., Kramer, J. R., Richardson, P. A., & Davila, J. A. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.019 · Cited by 648
Sangiovanni, A., Prati, G. M., Fasani, P., Ronchi, G., Romeo, R., Manini, M., Del Ninno, E., Morabito, A., & Colombo, M. (2006) · Hepatology · doi:10.1002/hep.21176 · Cited by 628
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
Projecting future complications of chronic hepatitis C in the United States
Davis, G. L., Albright, J. E., Cook, S. F., & Rosenberg, D. M. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50073 · Cited by 576
(2012) · PubMed · Cited by 570
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R., & McGlynn, K. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.048 · Cited by 546
Self-citationDonato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
Singal, A. G., & El-Serag, H. B. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.014 · Cited by 530
Self-citationZeuzem, S., Ghalib, R., Reddy, K. R., Pockros, P. J., Ari, Z. B., Zhao, Y., Brown, D. D., Wan, S., DiNubile, M. J., Nguyen, B.-Y., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0785 · Cited by 516
Welzel, T. M., Graubard, B. I., El–Serag, H. B., Shaib, Y. H., Hsing, A. W., Davila, J. A., & McGlynn, K. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.020 · Cited by 514
Self-citationWorld‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
de Martel, C., Maucort‐Boulch, D., Plummer, M., & Franceschi, S. (2015) · Hepatology · doi:10.1002/hep.27969 · Cited by 503
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El–Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.020 · Cited by 501
Self-citationSuryaprasad, A. G., White, J. Z., Xu, F., Eichler, B.-A., Hamilton, J., Patel, A., Hamdounia, S. B., Church, D. R., Barton, K., Fisher, C., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu643 · Cited by 500
Razavi, H., Waked, I., Sarrazin, C., Myers, R. P., Idilman, R., Calinas, F., Vogel, W., Mendes Correa, M. C., Hézode, C., Lázaro, P., et al. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12248 · Cited by 477
The global burden of disease attributable to contaminated injections given in health care settings
Hauri, A. M., Armstrong, G. L., & Hutin, Y. J. F. (2004) · International Journal of STD & AIDS · doi:10.1258/095646204322637182 · Cited by 458
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
White, D. L., Ratziu, V., & El-Serag, H. B. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.006 · Cited by 451
Self-citationChanging Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States
Altekruse, S. F., Henley, J. S., Cucinelli, J. E., & McGlynn, K. A. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.11 · Cited by 429
El‐Serag, H. B., Kanwal, F., Richardson, P., & Kramer, J. (2016) · Hepatology · doi:10.1002/hep.28535 · Cited by 411
Self-citationInternational trends in liver cancer incidence, overall and by histologic subtype, 1978–2007
Petrick, J. L., Braunlin, M., Laversanne, M., Valery, P. C., Bray, F., & McGlynn, K. A. (2016) · International Journal of Cancer · doi:10.1002/ijc.30211 · Cited by 342
Kanwal, F., Kramer, J. R., Ilyas, J., Duan, Z., & El-Serag, H. B. (2014) · Hepatology · doi:10.1002/hep.27095 · Cited by 322
Self-citationSeeff, L. B., Hollinger, B. F., Alter, H. J., Wright, E. C., Cain, C. M. B., Buskell, Z. J., Ishak, K. G., Iber, F. L., Toro, D., Samanta, A., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.21905 · Cited by 321
Extrahepatic manifestations of hepatitis C among United States male veterans
El-Serag, H. B., Hampel, H., Yeh, C., & Rabeneck, L. (2002) · Hepatology · doi:10.1002/hep.1840360621 · Cited by 314
Self-citationLarney, S., Kopinski, H., Beckwith, C. G., Zaller, N. D., Jarlais, D. D., Hagan, H., Rich, J. D., van den Bergh, B. J., & Degenhardt, L. (2013) · Hepatology · doi:10.1002/hep.26387 · Cited by 314
El‐Serag, H. B., Engels, E. A., Landgren, O., Chiao, E., Henderson, L., Amaratunge, H. C., & Giordano, T. P. (2009) · Hepatology · doi:10.1002/hep.22606 · Cited by 313
Self-citationSmith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y., Holtzman, D., & Ward, J. W. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-9-201211060-00529 · Cited by 302
HCV-associated liver cancer without cirrhosis
De Mitri, M. S., Pisi, E., Poussin, K., Paterlini, P., Bréchot, C., Baccarini, P., D'Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 294
Extrahepatic manifestations of chronic hepatitis C virus infection
Cacoub, P., Gragnani, L., Comarmond, C., & Zignego, A. L. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.10.005 · Cited by 293
Veldt, B. J., Chen, W., Heathcote, J. E., Wedemeyer, H., Reichen, J., Hofmann, P. W., de Knegt, R. J., Zeuzem, S., Manns, M. P., Hansen, B. E., et al. (2008) · Hepatology · doi:10.1002/hep.22251 · Cited by 284
Ryder, S. D. (2004) · Gut · doi:10.1136/gut.2003.021691 · Cited by 276
The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans
El-Serag, H. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02617-x · Cited by 274
Self-citationHistorical epidemiology of hepatitis C virus (HCV) in selected countries
Bruggmann, P., Berg, T., Øvrehus, A. L. H., Moreno, C., Brandão Mello, C. E., Roudot‐Thoraval, F., Marinho, R. T., Sherman, M., Ryder, S. D., Sperl, J., et al. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12247 · Cited by 261
Mittal, S., Sada, Y. H., El-Serag, H. B., Kanwal, F., Duan, Z., Temple, S., May, S. B., Kramer, J. R., Richardson, P. A., & Davila, J. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.013 · Cited by 261
Self-citationShaib, Y. H., El-Serag, H. B., Nooka, A. K., Thomas, M., Brown, T. D., Patt, Y. Z., & Hassan, M. M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01104.x · Cited by 258
Self-citationThe natural course of chronic hepatitis C
Iwarson, S. (1994) · FEMS Microbiology Reviews · doi:10.1016/0168-6445(94)90033-7 · Cited by 238
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*
Hatzakis, A., Wait, S., Bruix, J., Buti, M., Carballo, M., Cavaleri, M., Colombo, M., Delarocque‐Astagneau, E., Dusheiko, G., Esmat, G., et al. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01499.x · Cited by 235
Raimondi, S., Bruno, S., Mondelli, M. U., & Maisonneuve, P. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.019 · Cited by 224
Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study
Lee, T. Y., Lee, S. S., Jung, S. W., Jeon, S. H., Yun, S.-C., Oh, H.-C., Kwon, S., Lee, S. K., Seo, D. W., Kim, M.-H., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01796.x · Cited by 217
Shi, J., Zhu, L., Liu, S., & Xie, W.-F. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602333 · Cited by 215
Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N., Kobayashi, M., Sezaki, H., Saito, S., Hosaka, T., et al. (2013) · Hepatology · doi:10.1002/hep.26087 · Cited by 191
Gibson, T. M., Morton, L. M., Shiels, M. S., Clarke, C. A., & Engels, E. A. (2014) · AIDS · doi:10.1097/qad.0000000000000428 · Cited by 190
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
Yamamoto, S., Kubo, S., Hai, S., Uenishi, T., Yamamoto, T., Shuto, T., Takemura, S., Tanaka, H., Yamazaki, O., Hirohashi, K., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02492.x · Cited by 187
Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study
Wiese, M., Grüngreiff, K., Güthoff, W., Lafrenz, M., Oesen, U., & Porst, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.007 · Cited by 187
Pekow, J. R., Bhan, A. K., Zheng, H., & Chung, R. T. (2007) · Cancer · doi:10.1002/cncr.22701 · Cited by 185
Nkontchou, G., Ziol, M., Aout, M., Lhabadie, M., Baazia, Y., Mahmoudi, A., Roulot, D., Ganne-Carrie, N., Grando-Lemaire, V., Trinchet, J.-C., et al. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01441.x · Cited by 179
Therapy for Hepatitis C Virus–Related Cryoglobulinemic Vasculitis
Dammacco, F., & Sansonno, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208642 · Cited by 178
Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China
Zhou, Y.-M., Yin, Z.-F., Yang, J.-M., Li, B., Shao, W.-Y., Xu, F., Wang, Y.-L., & Li, D.-Q. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.632 · Cited by 171
Allison, R. D., Tong, X., Moorman, A. C., Ly, K. N., Rupp, L., Xu, F., Gordon, S. C., & Holmberg, S. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.021 · Cited by 168
Probst, A., Dang, T., Bochud, M., Egger, M., Negro, F., & Bochud, P.-Y. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01481.x · Cited by 161
Anderson, L. A., Murphy, S. J., Johnston, B. T., Watson, R. G. P., Ferguson, H. R., Bamford, K. B., Ghazy, A., McCarron, P., McGuigan, J., Reynolds, J. V., et al. (2008) · Gut · doi:10.1136/gut.2007.132662 · Cited by 161
Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 3
Liakina, V., Hamid, S., Tanaka, J., Olafsson, S., Sharara, A. I., Alavian, S. M., Gheorghe, L., El Hassan, E. S., Abaalkhail, F., Abbas, Z., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12475 · Cited by 158
Gisbert, J. P., García-Buey, L., Pajares, J. M., & Moreno‐Otero, R. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00346-5 · Cited by 154
Trinchet, J., Bourcier, V., Chaffaut, C., Ait‐Ahmed, M., Allam, S., Marcellin, P., Guyader, D., Pol, S., Larrey, D. G., de Lédinghen, V., et al. (2015) · Hepatology · doi:10.1002/hep.27743 · Cited by 153
Hepatitis C Disease Burden in the United States in the era of oral direct‐acting antivirals
Chhatwal, J., Wang, X., Ayer, T., Kabiri, M., Chung, R. T., Hur, C., Donohue, J. M., Roberts, M. S., & Kanwal, F. (2016) · Hepatology · doi:10.1002/hep.28571 · Cited by 149
Self-citationThe Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions
Kabiri, M., Jazwinski, A. B., Roberts, M. S., Schaefer, A. J., & Chhatwal, J. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0095 · Cited by 142
The impact of hepatitis C burden: an evidence‐based approach
Younossi, Z. M., Kanwal, F., Saab, S., Brown, K., El‐Serag, H. B., Kim, W. R., Ahmed, A., Kugelmas, M., & Gordon, S. C. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12625 · Cited by 129
Self-citationTanaka, Y., Kurbanov, F., Mano, S., Orito, E., Vargas, V., Esteban, J. I., Yuen, M., Lai, C., Kramvis, A., Kew, M. C., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.032 · Cited by 128
Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance
Re, V. L., Gowda, C., Urick, P. N., Halladay, J. T., Binkley, A., Carbonari, D. M., Battista, K., Peleckis, C., Gilmore, J., Roy, J. A., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.03.040 · Cited by 127
Hatzakis, A. E., Chulanov, V., Gadano, A. C., Bergin, C. J., Ben‐Ari, Z., Mossong, J., Schréter, I., Baatarkhuu, O., Acharya, S. K., Aho, I., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12351 · Cited by 125
Natural course of chronic hepatitis C.
Takahashi, M., Yamada, G., Miyamoto, R., Doi, T., Endo, H., & Tsuji, T. (1993) · PubMed · Cited by 123
Viral hepatitis and the G lobal B urden of D isease: a need to regroup
Cooke, G., Lemoine, M., Thursz, M. R., Gore, C., Swan, T., Kamarulzaman, A., du Cros, P., & Ford, N. P. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12123 · Cited by 122
Cho, L. Y., Yang, J. J., Ko, K., Park, B., Shin, A., Lim, M. K., Oh, J., Park, S., Kim, Y. J., Shin, H., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25321 · Cited by 120
Greenaway, C., Ma, A. T., Kloda, L. A., Klein, M. B., Cnossen, S., Schwarzer, G., & Shrier, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141715 · Cited by 120
Chang, K.-C., Hung, C., Lu, S.-N., Wang, J.-H., Lee, C.-M., Chen, C., Yen, M.-F., Lin, S., Yen, Y., Tsai, M., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks269 · Cited by 103
Sansonno, D. E., Lauletta, G., Montrone, M., Grandaliano, G., Schena, F. P., & Dammacco, F. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02778.x · Cited by 101
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case–control study in China
Tao, L., He, X., Qu, Q., Cai, L., Liu, W., Zhou, L., & Zhang, S.-M. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02149.x · Cited by 100
Progression to cirrhosis in hepatitis C patients: an age‐dependent process
Pradat, P., Voirin, N., Tillmann, H. L., Chevallier, M., & TREPO, C. G. (2007) · Liver International · doi:10.1111/j.1478-3231.2006.01430.x · Cited by 99
Reig, M., Mariñó, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Cited by 95
Ganne‐Carrié, N., Layese, R., Bourcier, V., Cagnot, C., Marcellin, P., Guyader, D., Pol, S., Larrey, D. G., de Lédinghen, V., Ouzan, D., et al. (2016) · Hepatology · doi:10.1002/hep.28702 · Cited by 95
Historical epidemiology of hepatitis C virus ( HCV ) in select countries – volume 2
Saraswat, V. A., Norris, S., de Knegt, R. J., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12350 · Cited by 92
Hassan, M. M., Spitz, M. R., Thomas, M. B., El‐Deeb, A. S., Glover, K. Y., Nguyen, N. T., Chan, W., Kaseb, A. O., Curley, S. A., Vauthey, J., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23730 · Cited by 91
Sibley, A., Han, K., Abourached, A., Lesmana, L. A., Makara, M., Jafri, W., Salupere, R., Assiri, A. M., Goldiș, A., Abaalkhail, F. A., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12476 · Cited by 79
Lü, M., Li, J., Zhang, T., Rupp, L. B., Trudeau, S., Holmberg, S. D., Moorman, A. C., Spradling, P. R., Teshale, E. H., Xu, F., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.01.009 · Cited by 63
Lee, B. S., Park, E.-C., Park, S. W., Nam, C. M., & Roh, J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i2.502 · Cited by 51
Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM
Sherman, A. C., & Sherman, K. E. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0274-8 · Cited by 47
Ferenci, P., Ferenci, S., Datz, C., Rezman, I., Oberaigner, W., & Strauß, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.023 · Cited by 47
Adverse Outcomes in Alaska Natives Who Recovered From or Have Chronic Hepatitis C Infection
McMahon, B. J., Bruden, D. J. T., Bruce, M. G., Livingston, S., Christensen, C., Homan, C., Hennessy, T. W., Williams, J. L., Sullivan, D., Rosen, H. R., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.10.056 · Cited by 45
Case control study to identify risk factors for acute hepatitis C virus infection in Egypt
Kandeel, A., Talaat, M., Afifi, S., El-Sayed, N., Fadeel, M. A., Hajjeh, R. A., & Mahoney, F. J. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-294 · Cited by 42
Lemoine, M., & Thursz, M. R. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1371082 · Cited by 37
Costanzo, G. G. D., Luca, M. D., Tritto, G., Lampasi, F., Addario, L., Lanza, A. G., Tartaglione, M. T., Picciotto, F. P., & Ascione, A. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f762e1 · Cited by 22
Outcome of hepatitis C infection: Bleak or benign?
Ryder, S. D. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.006 · Cited by 12
Beck, E. J., Passarelli, C., Lui, I., Guichard, A.-C., Simão, M. B. G., Lay, P. R. D., & Loures, L. (2013) · Antiviral Therapy · doi:10.3851/imp2906 · Cited by 10
Cited by
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Self-citationEpidemiology and Management of Hepatocellular Carcinoma
Kulik, L., & El-Serag, H. B. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.08.065 · Cited by 1,735
Self-citationLiver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,160
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline
Shaheen, N. J., Falk, G. W., Iyer, P. G., Souza, R. F., Yadlapati, R. H., Sauer, B. G., & Wani, S. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001680 · Cited by 510
Autophagy in hepatic adaptation to stress
Hazari, Y., Bravo-San Pedro, J. M., Hetz, C., Galluzzi, L., & Kroemer, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.026 · Cited by 151
Metadata
- Authors
- Thrift, A. P., El-Serag, H. B., & Kanwal, F.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2016-12-07
- Volume
- 14
- Issue
- 2
- Pages
- 122-132
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2560002598
- Cited by
- 382
- References
- 109
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.